CACaption Management, LLC
Institutional investor · Portfolio as of Q1 2020
Top Holdings822 positions
Stock | Shares | Value | Weight | Avg Buy | Est. P&L | Held | Conviction |
|---|---|---|---|---|---|---|---|
CHIPOTLE MEXICAN GRILL INC | 78,200 | $51.2M | 2.9% | — | — | — | Increased — |
SPDR DOW JONES INDUSTRIAL AVERAGE ETF TRUST ETF | 100,000 | $21.9M | 1.2% | — | — | — | New — |
AMERICAN TOWER CORP | 100,000 | $21.8M | 1.2% | — | — | — | New — |
TRANSDIGM GROUP INC | 67,800 | $21.7M | 1.2% | — | — | — | New — |
ALIBABA GROUP HOLDING-SP ADR | 100,000 | $19.4M | 1.1% | — | — | — | New — |
AXSOME THERAPEUTICS INC | 306,400 | $18M | 1.0% | — | — | — | New — |
BIOMARIN PHARMACEUTICAL INC | 204,000 | $17.2M | 1.0% | — | — | — | Increased — |
ISHARES US REAL ESTATE ETF | 235,400 | $16.4M | 0.9% | — | — | — | New — |
AVI BIOPHARMA INC | 155,000 | $15.2M | 0.9% | — | — | — | Increased — |
P G & E CORP | 1.6M | $14.6M | 0.8% | — | — | — | Decreased — |
ISHARES MSCI INDIA ETF | 590,000 | $14.2M | 0.8% | — | — | — | New — |
GENERAL ELECTRIC CO | 1.8M | $14.2M | 0.8% | — | — | — | — |
EQUINIX INC | 22,500 | $14.1M | 0.8% | — | — | — | New — |
STATE STREET SPDR S&P 500 ETF TRUST CL USD INC | 52,000 | $13.4M | 0.8% | — | — | — | New — |
SEA LTD-ADR | 300,000 | $13.3M | 0.8% | — | — | — | New — |
REGENERON PHARMACEUTICALS | 26,200 | $12.8M | 0.7% | — | — | — | New — |
ZENDESK INC | 199,000 | $12.7M | 0.7% | — | — | — | Decreased — |
SUNRUN INC | 1.2M | $12.6M | 0.7% | — | — | — | Decreased — |
MYOKARDIA INC | 267,600 | $12.5M | 0.7% | — | — | — | New — |
ZENDESK INC | 190,000 | $12.2M | 0.7% | — | — | — | Increased — |
Caption Management, LLC manages $1.8B across 822 positions as of Q1 2020. Top holdings: CMG (2.9%), DIA (1.2%), AMT (1.2%). Fund DNA: Momentum Trader. HoldingsIntel Rating: 1/5.0.
Active quarter - 178 new positions, 161 exits, 62 increased. No standout high-conviction moves this quarter. Portfolio: $1.8B across 822 positions.
Top holdings by portfolio weight
Portfolio allocation by GICS sector
Behavioral investing profile
Position Outcomes
Best and worst performing positions by estimated return
Top Winners
Top Losers
Cost basis estimates based on full filing history using quarter-end prices. Actual transaction prices are not disclosed in 13F filings.
Similar Funds
Funds with similar investing DNA
Explore More
Accumulation Streaks
Positions with 2+ consecutive quarters of increases - persistent directional conviction.
Continue exploring
Data sourced from SEC EDGAR 13F filings. Not financial advice. Full disclaimer